| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.2B | $1.1B | $1.1B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | $0.2B | $0.2B | $0.2B | $0.2B | — |
| Operating Income | — | — | — | — | — |
| Net Income | $0.7B | — | — | — | $0.5B |
| EPS (Basic) | $4.54 | $4.40 | $4.14 | $4.32 | $3.36 |
| EPS (Diluted) | $4.52 | $4.37 | $4.11 | $4.31 | $3.36 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $6.9B | $6.5B | $6.2B | $5.7B | $5.9B |
| Current Assets | — | — | — | — | — |
| Cash & Equivalents | $0.6B | $0.6B | $0.6B | $0.5B | $0.4B |
| Total Liabilities | $1.5B | $1.5B | $1.6B | $1.6B | $1.8B |
| Current Liabilities | — | — | — | — | — |
| Stockholders' Equity | $5.4B | $5.0B | $4.6B | $4.1B | $4.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.7B | $0.6B | $0.6B | $0.6B |
| Investing Cash Flow | $-0.2B | $-0.3B | $-0.2B | $-0.2B | $-0.4B |
| Capital Expenditures | — | — | — | — | — |
| Financing Cash Flow | $-0.5B | $-0.4B | $-0.3B | $-0.3B | $-0.2B |